AFP and hepatocellular carcinoma: cfDNA post-resection predicts recurrence better than AFP (206). Multi-marker models (cSMART (207), mt-HBT (208), PreCar (209)) improve early HCC detectionMYCN (220), protein/autoantibody panels (221, 222), and spectroscopy (223) outperform AFP in specific contexts